In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Why Promising Peptides Will Never Be "Proven" The Hidden Economics Behind Therapies Your Doctor Can't Recommend SAC Law Offices of Stephenson Acquisto & Colman What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B Is BPC 157 Banned? Oral vs. Injectable Forms Explained